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ConCLuSion
From the results obtained in the current 
study, the relative proportion of these flavonoids 
was reduced by maceration conventional techni-
que, while microwave and ultrasonic techniques 
in combination with 70% ethanol solvent were the 
most efficient. It may suggest that microwave and 
ultrasonic methods using 70% ethanol are suitable 
for fast extraction of flavonoids in a simple way, 
also considering extraction yield and extraction 
time. These methods also permitted the acquisi-
tion of flavonoids from reduced raw plant mate-
rial.
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resumo: O presente estudo teve como objetivo verificar a melhor metodologia de extração para rápida 
e eficiente obtenção de flavonóides a partir de Alpinia zerumbet. Folhas secas foram extraídas com água 
destilada e etanol 70%, utilizando as metodologias de extração: maceração sob agitação, ultrassom, 
microondas e agitador. Para verificação dos flavonóides rutina e kaempferol-3-O-glicuronídeo foram 
utilizadas as técnicas de CCD e CLAE em fase reversa. O solvente etanol 70% foi mais eficiente como 
extrator. Para as metodologias ultrassom, microondas e agitador, não houve variação significativa para 
o rendimento utilizando etanol 70% (11 a 14%). A concentração relativa de rutina e kaempferol-3-O-
glicuronídeo, respectivamente, foi maior pelos métodos de extração por ultrassom (1,5 e 5,62 mg g-1 
folha seca) e microondas (1,0 e 6,64 mg g-1 folha seca), utilizando etanol 70%. Procedimentos rápidos e 
simplificados de extração otimizam o trabalho fitoquímico e a obtenção de metabólitos secundários.
Palavras-chave: cromatografia líquida de alta eficiência, maceração, microondas, ultrassom, Zingiberaceae
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Abstract: A qualitative spot-test and tandem quantitative analysis of dipyrone in the bulk drug 
and in pharmaceutical preparations is proposed. The formation of a reddish-violet color in-
dicates a positive result. In sequence a quantitative procedure can be performed in the same 
flask. The quantitative results obtained were statistically compared with those obtained with 
the method indicated by the Brazilian Pharmacopoeia, using the Student’s t and the F tests. 
Considering the concentration in a 100 µL aliquot, the qualitative visual limit of detection is 
about 5×10-6 g; instrumental LOD ≅ 1.4×10-4 mol L-1 ; LOQ  ≅ 4.5×10-4  mol L-1.
Keywords: dipyrone, spot-test, analysis, qualitative, quantitative
introduction
Dipyrone (sodium salt of 1-phenyl-2,3-di-
methyl-4-methylaminomethane-sulfonate-5-pyra-
zolone) (Fig. 1) is a water-soluble pyrazolone de-
rivative widely used in therapeutics as a analgesic, 
antipyretic and antispasmodic drug [1]. Dipyrone 
was developed in Germany and was introduced 
into clinical practice in 1922. It is still in use in 
many countries for adults and children, where it is 
sold as an over-the counter (OTC) painkiller [2,3]. 
Due to its strong analgesic effect, available paren-
teral formulation, and low cost, dipyrone is wide-
ly used, generating a consumption of more than 
10 thousand tons/year. Dipyrone is very popular 
in Brazil and is marketed in the sodium salt form 
or as the magnesium salt, as well as in association 
with other drugs [4].  However, the use of dipy-
rone was proscribed more than twenty years ago 
in the U.S.A. due to its putative role in depressing 
bone marrow, causing aplastic anemia and agran-
ulocytosis. However, this has been criticized by 
many authors [2,4,5].
Figure1. Structural formula of dipyrone.
The metabolism of dipyrone has been re-
cently reviewed. It was demonstrated that it inhi-
bits cyclooxygenase (COX). However, in contrast 
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to classical COX-inhibitors, such as aspirin-like 
drugs, dipyrone has no anti-inflammatory effect 
and a low gastrointestinal toxicity, indicating a 
different mode of action. The authors suggested 
that the pharmacologically active metabolites of 
dipyrone inhibit COX activity by sequestering 
radicals that initiate the catalytic activity of this 
enzyme or through the reduction of the oxidized 
states of the COX protein [6]. After oral intake, 
it is spontaneously hydrolyzed in the gastric fluid 
to its main metabolite, 4-methylaminoantipyrine 
(4-MAA), which is rapidly and nearly completely 
absorbed. 4-MAA is then converted to variety of 
metabolites by various enzymatic reactions. The 
effect of dipyrone occurs approximately fifteen 
minutes after oral administration. The biotransfor-
mation takes place at the hepatic level, the dura-
tion of this effect is approximately 4-6 hours, and 
its elimination occurs at the renal level [7].
Recently, additional beneficial effects of 
dipyrone, such as vascular smooth muscle rela-
xation, and as antiapoptotics and anticolvulsants, 
have been reported and have increased the interest 
in dipyrone [3].
A great problem related with pharmaceuti-
cal products around the world is falsification. The-
se incidents probably occur more frequently in de-
veloping and poor countries but certainly Europe 
and United States are not completely free of them. 
In Brazil the problem was denounced some years 
ago [8,9] and involved antibiotics, contraceptives, 
cancer medicines and also common analgesics and 
antipyretics like dipyrone and aspirin. There is 
suspicion that such anomalies still remain.  From 
these considerations, it is clearly apparent that it 
is very important to develop quick, simple, relia-
ble and low cost analytical procedures that could 
be used routinely for screening examinations to 
detect possible falsifications.
Some methods have been developed for 
dipyrone determination, such as titrimetry [1], 
HPLC [10], spectrophotometry [11-15], poten-
tiometry [16], amperometry [17,18], turbidimetry 
[19], voltammetry [20], and reflectometry [21]. 
The iodometric titration of dipyrone is recommen-
ded by the Pharmacopoeia [1] but this procedure 
is very slow and laborious, thus less applicable to 
large-scale analysis. 
The aim of the present work is to develop 
a simple and reliable spectrophotometric method 
for the qualitative spot-test [22] associated with a 
rapid quantitative sequential analysis of dipyrone 
in pharmaceutical preparations. A similar qualita-
tive procedure has been reported [23] but in the 
present work the sequential quantitative analysis 
using iron III as catalyst was developed.  The me-
thod is based on the selective oxidation of dipyro-
ne, a characteristic reaction of a pyrazolone, in the 
presence of concentrated sulfuric acid, splitting 
off formaldehyde which reacts with chromotropic 
acid producing a reddish-violet compound [11]. 
The sulfuric acid addition promotes the oxidation 
of dipyrone and guarantees the temperature neces-
sary for the reaction, to occur, as it interacts with 
the small quantity of water intentionally added in 
order to take advantage of the highly exothermic 
process of the hydration of this acid. The forma-
tion of the reddish-violet compound identifies the 
dipyrone. In case of positive qualitative result the 
quantitative analysis can be sequentialy perfor-
med.
experimental
Reagents
All chemicals were of analytical gra-
de and were used without further purification. 
Concentrated sulfuric acid (96%) was obtained 
from Synth®. Chromotropic acid (disodium salt, 
dihydrate, C10H6O8S2Na2.2H2O) and dipyrone 
(C13H16N3NaO4S) were obtained from Sigma-Al-
drich®. Distilled water was obtained from a glass 
distillation device.
Pharmaceutical dosage forms of dipyrone 
were purchased from reliable drugstores. The 
commercial tablets comprising dipyrone tested 
were: - Novalgina (500 mg); Conmell (320 
mg); Anador (500 mg); Lisador (500 mg); 
Buscopan (250 mg) and Generic Medley (500 
mg).
Solutions
Chromotropic acid solution: prepared daily 
by dissolving 0.2002 g of chromotropic acid in 5 
mL of distilled water, in order to obtain a 0.1 mol 
L 1 concentration.
iron (iii) chloride 0.1 mol L-1 solution: to 
prepare 25 mL of a 0.1 mol L-1 solution about 0.67 
g of analytical grade (Vetec®) FeCl3.6H2O were 
dissolved in a volumetric flask.
Standard dipyrone solution:  prepared by 
dissolving an adequate mass of dipyrone in 50.0 
mL of distilled water, in order to obtain a 0.1 mol 
L 1 concentration. From this solution, by appro-
priate dilutions, the other solutions of the dipyro-
ne were prepared.
Sample preparation: Twenty tablets were 
powdered in a mortar after weighing. An accura-
tely weighed portion of one tablet, equivalent to 
about 15 mg of anhydrous dipyrone, was dissol-
ved in 10.0 mL of water, in a volumetric flask, to 
obtain a solution with a concentration of approxi-
mately 4.5 × 10 -3 mol L-1.
Procedure
Add, with a micro spatula, to the tube 
(straight walled volumetric flask of 5.0 mL) about 
2 to 3 mg of solid chromotropic acid. Transfer ca-
refully 100 μL of dipyrone solution into this tube. 
Gently dissolve the chromotropic acid. Add a drop 
of the 0.1 mol L-1 iron (III) chloride solution and 
homogenize. Then add 500 μL of good quality 
concentrated sulfuric acid.  The acid should be 
rapidly added, all at once. Shake the tube care-
fully in order to homogenize. If a reddish-violet 
color appears the test is positive for dipyrone. To 
sequentially perform the quantitative analysis the 
volume is completed to 5.0 mL with water.  The 
absorbance is measured at 576 nm using the volu-
metric flask as the spectrophotometric cell. Alter-
natively spectrophotometric cuvettes can be used.
Apparatus
A Femto 600 single beam spectrophotome-
ter was used for all absorbance measurements. The 
absorbance measurements were performed using a 
straight walled volumetric flask also used for the 
reaction. Spectrophotometric glass cuvettes 1.00 
cm optical path were also used.
The 5.00 mL straight walled volumetric 
flask used is essentially an adequately calibrated 
tube with 11 cm total height, 1.0 cm ID, 1.4 cm 
OD and fitted with a stopper to allow shaking wi-
thout losing solution. It is similar to the usual 1.0 
and 2.0 volumetric flasks. This format was used in 
order to promote the most intimate contact of the 
analyte and of the reagents due to the format and 
to the dimensions of the bottom of the flask.
As the volumetric tubes were not of optical 
quality their transmittance (filled with water) at 
576 nm was compared. No significant difference 
was observed and, therefore, they were used wi-
thout necessity of any correction in the measured 
absorbances.
Volume measurements of the aliquots and 
of the sulfuric acid were done using Eppendorf® 
micropipettes.
Reference method
To analyze the samples by the classic 
iodometric method, the preparation procedure 
recommended by the Brazilian  Pharmacopoeia 
[1] was used.
Statistical analysis
The statistical t-Student test and the F tests 
[24] were applied to compare the recovery results 
obtained by the two analytical methods, the pro-
posed and the titrimetric ones [1].  
results and Discussion
The reaction used in the method developed 
in this work is based on the reaction  of dipyrone 
analogue, 1-phenyl-2,3-dimethyl-4-dimethylami-
no-5-pyrazolone [22], which makes use of  a very 
selective oxidation of that compound in the pre-
sence of concentrated sulfuric acid, splitting out 
formaldehyde. The reducing action of pyramido-
ne is related to its tendency to tautomerise [25]; 
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the oxidation probably begins with the isomeric 
methoxy form of the pyrazolone [22]. The for-
maldehyde formed is identified by reacting it with 
warm chromotropic acid, yielding a red-violet co-
lor [22]. The nature of this chromogen has never 
been unambiguously determined but some expe-
rimental evidence suggests the hypothesis that it 
has a mono-cationic dibenzoxanthylium structure 
[26]. In this work, we use the highly exothermic 
hydration process of the sulfuric acid and its very 
low heat capacity to provoke the necessary tem-
perature increase for the reaction to occur [23]. In 
order to accelerate the reaction iron III was used 
as catalyst. A drop of a 0.1 mol L-1 iron (III) chlo-
ride solution was added directly in the solution 
containing the dipyrone with the chromotropic 
acid. When the sulfuric acid is added, the increase 
of the reaction rate can be visually observed when 
compared to the reaction without the addition of 
iron III.
The absorption spectrum of the reaction 
product was obtained using the final solution in 
the volumetric flask. With the defined working 
conditions the maximum absorption wavelength 
was observed at 576 nm.  
The stability of the product formed was stu-
died over time. Measurements performed 15 days 
later showed that the reddish-violet compound 
formed is completely stable in this time interval 
when stored at ambient temperature (ca. 25 oC).
The molar ratio of the analyte to the 
analytical reagent and the volume ratio of the con-
centrated sulfuric acid were investigated. The best 
conditions were: 1:10 ratio of dipyrone to chro-
motropic acid using 500 µL of concentrated sul-
furic acid.
The absorbance was measured at 576 nm 
using the volumetric flask as spectrophotometric 
cell. These results were compared with those ob-
tained with spectrophotometric cuvettes.  
The calibration curves were constructed in 
the range from 1.0 × 10-3 mol L-1 to 6.0 × 10 3 mol 
L-1 considering the concentration in the aliquot. 
They can be described by the equations: a) A = 
0.15 + 110 C (r=0.999) where A is the absorbance 
at 576 nm and C is the concentration in mol L-1 
in the aliquot; when using the spectrophotometer 
with the straight walled volumetric flask and b) A 
= 0.16 + 114 C (r=0.998) with the cuvettes.
For both procedures, using the volumetric 
tubes for spectrophotometric measurements or 
using the cuvettes, the instrumental limits of de-
tection, LOD, and of quantitation, LOQ, are: LOD 
≅ 1.4 × 10-4 mol L-1 (LOD ≅ 3.3 SD / slope); limit 
of quantitation LOQ ≅ 4.5 × 10-4  mol L-1 (LOQ 
≅ 10 SD / slope). The visual qualitative limit of 
detection is about 5 × 10-6 g of dipyrone in the 
aliquot.
Alternatively, in order to obtain results 
more rapidly, a simple proportional calculation 
can be done using as standard a solution prepa-
red with the expected concentration of dipyrone in 
the sample. If the obtained result for the sample is 
within the established limits, the pharmaceutical 
preparation can be considered in conformity with 
the pharmacopoeia recommendations. 
In order to test the proposed method six 
commercial pharmaceutical preparations, pur-
chased in local pharmacies, were analyzed. The 
results were compared with those obtained with 
the titrimetric procedure recommended by the 
Brazilian Pharmacopoeia [1], using the paired 
Student’s statistical t test and the F test [24]. As it 
can be observed in Table 1, for a confidence coe-
fficient of 0.05, in four cases values of t, slightly 
higher than the theoretical value, were obtained. 
However, the F test shows complete agreement in 
all cases. For the confidence coefficient of 0.01 
complete agreement was achieved in the Student’s 
t and in the F tests.
table 1. Comparison, using the paired statistical t test of Student and the F test, between the results obtained 
with the titrimetric Brazilian Pharmacopoeia procedure and those obtained with the method proposed in this 
work.
Sample a Label values/mg Refer.b Proposed I c Proposed II d tI e tII f FI g FII h FI-II i
A 500 500 ± 3 507 ± 10 504 ± 3 0.95 1.33 11.1 1.0 11.1
B 320 320 ± 2 312± 8 330± 6 1.37 3.16 16.0 9.0 1.8
C 500 494± 2 491 ± 1 498 ± 4 2.68 1.26 4.0 4.0 16.0
D 500 504±3 512 ± 1 495± 3 3.58 3.00 6.0 1.0 9.0
E 500 518 ±3 501± 6 498 ± 5 3.62 2.43 4.0 2.8 1.4
F 250 245 ±3 258± 3 246 ± 2 4.33 0.39 1.0 2.3 2.3
aOther components present in the pharmaceutical 
preparation besides dipyrone: 
A- magnesium stearate; macrogol; 
B - starch; lactose; talc; magnesium stearate; 
C - hypromelose; polyvidone; silicon dioxide; su-
crose; quinoline yelow; starch; talc; magnesium 
stearate; 
D - prometazin hydrochloride, adiphenine hydro-
chloride, magnesium stearate; silicon dioxide; 
talc; starch; sucrose; 
E - silicon dioxide; magnesium stearate; polyvi-
done, magnesium silicate; 
F - hyoscine butylbromide, calcium phosphate 
dibasic; starch; silicon dioxide; tartaric acid; ste-
aric acid; polyvidone; sucrose; talc; gum arabic; 
titanium dioxide; macrogol;carnauba wax; white 
wax.
b Reference titrimetric method [1].
c Proposed method I,  using straight volumetric 
tubes.
d Proposed method II, using spectrophotometric 
cuvettes.
e Paired calculated Student’s t values, comparing 
the proposed method I with the reference titrimet-
ric method.
f Paired calculated Student’s t values, comparing 
the proposed method II with the reference titri-
metric method.
g F values comparing method I with reference tit-
rimetric method.
h F values comparing method II with reference tit-
rimetric method
i F values comparing method I with method II.
Theoretical: Students’s t = 2.78 (confidence coef-
ficient, α=0.05) and 4.60 (confidence coefficient, 
α=0.01) for the degree of freedom ν= 4 (ν= n1 + 
n2 -2); n1 = n2 = 3; F = 19.00 (α=0.05).
Conclusion
The analytical method described in this 
work, despite the complexity of the analyte, pres-
ents extreme chemical and instrumental simplic-
ity, very low cost, quite good accuracy and pre-
cision, rapidity and reliability. The quantitative 
determination can be performed in less than five 
minutes. Therefore, considering these characteris-
tics, it can be suggested for the determination of 
dipyrone in the bulk drug and in pharmaceutical 
preparations.
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resumo: Um método “spot-test” qualitativo e seqüencialmente quantitativo é proposto para 
análise de dipirona em fármaco “puro” e em preparações farmacêuticas. A formação de colora-
ção vermelho-violeta indica um resultado qualitativo positivo. Na seqüência, um procedimento 
quantitativo pode ser realizado no mesmo frasco. Os resultados quantitativos obtidos foram 
comparados estatisticamente com os resultados obtidos pelo método indicado pela Farmaco-
péia Brasileira, utilizando o teste t de Student e o teste F. Considerando a concentração em 
uma alíquota de 100 µL, o limite qualitativo visual de detecção foi de cerca 5×10-6 g; instru-
mentalmente o limite de detecção foi de LOD  ≅  1.4×10-4 mol L-1 e o limite de quantificação 
de LOQ ≅ 4.5×10-4  mol L-1.
Palavras-chave: dipirona, spot-test, análise, qualitativa, quantitativa 
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Abstract: Maranhão state in Brazil presents a big potential for the cultivation of several olea-
ginous species, such as babassu, soybean, castor oil plant, etc... These vegetable oils can be 
transformed into biodiesel by the transesterification reaction in an alkaline medium, using 
methanol or ethanol. The biodiesel production from a blend of these alcohols is a way of 
adding the technical and economical advantages of methanol to the environmental advantages 
of ethanol. The optimized alcohol blend was observed to be a methanol/ethanol volume ratio 
of 80 % MeOH: 20 % EtOH. The ester content was of 98.70 %, a value higher than the target 
of the ANP, 96.5 % (m/m), and the biodiesel mass yield was of 95.32 %. This biodiesel fulfills 
the specifications of moisture, specific gravity, kinematic viscosity and percentages of free 
alcohols (methanol plus ethanol) and free glycerin.
Keywords: Babassu oil, methanol, ethanol, methyl esters, ethyl esters.
i. introduction
Babassu nut is the main product of the vege-
tal extractive activities in Maranhão state, Brazil, 
and one quarter of its territory is covered by such 
native palm tree (Orbignya phalerata). The activi-
ties related to the babassu nut generate about 300 
thousand jobs, from the collect normally made by 
the “babassu breakers”, up the oil refining [1,2].
Maranhão is the biggest producer of ba-
bassu nuts in Brazil. It is responsible for the 
production of almost 80% of the country output, 
corresponding to 120 thousand metric tons in the 
2005 base year. [3]. The local industries produce 
about 60 thousand metric tons /year of babassu 
oil, being most of it transported to other Brazilian 
states [4].
Babassu oil displays a high percentage of 
saturated fatty acids, 91%, mainly composed of 
lauric acid (48%), myristic acid (16%), palmitic 
acid (10%), stearic acid (2%) and others (5%). It 
also presents 19% of unsaturated fatty acids, chie-
fly oleic (14%) and linoleic (5%) acids [5].
Maranhão is also the second biggest soy-
bean producer in Northeastern Brazil, only behind 
Bahia state. In the 2006/2007 harvest, according 
to CONAB, the soybean production in Maranhão 
was of about 0.967 million metric tons, while 
the whole Brazilian output was of around 56.71 
million metric tons [6].
Besides these two cultures, Maranhão dis-
plays a big potential for the cultivation of other 
oleaginous species (castor oil plant, cotton, tame 
nut, etc.), due to its weather conditions, geogra-
Ecl. Quím., São Paulo, 35(1): 47 - 54, 2010
